1.490EUR-0.67%Mkt Cap: 19.30M EURP/E: —Last update: 2026-05-14
NanoRepro AG engages in the development, manufacture, and distribution of rapid diagnostic tests and food supplements for home and professional use in Germany and internationally. The company provides products in the are…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-38.25
PEG—
P/B0.52
P/S3.74
EV/EBITDA-5.29
EV/Revenue2.32
EPS (TTM)-0.14
EPS (Forward)-0.04
Cash Flow & Leverage
FCF Yield—
FCF Margin—
Operating CF9.86M EUR
CapEx (TTM)402.60K EUR
Net Debt/EBITDA3.21
Net Debt-7.29M EUR
Technical
SMA 501.476 (+0.9%)
SMA 2001.588 (-6.2%)
Beta0.42
S&P 52W Chg24.23%
Avg Vol (30d)6.56K
Avg Vol (10d)5.44K
Technical Indicators
RSI (14)47.7
MACD0.0048
MACD Signal0.0117
MACD Hist.-0.0069
BB Upper1.575 EUR
BB Middle1.521 EUR
BB Lower1.466 EUR
BB Width7.16%
ATR (14)0.0588 EUR
Vol Ratio (20d)0.51x
52W Range
1.16534% of range2.120
52W High2.120 EUR
52W Low1.165 EUR
Profitability
Gross Margin63.38%
EBITDA Margin-43.91%
Profit Margin-44.02%
Oper. Margin-38.37%
ROE-5.36%
ROA-5.24%
Revenue Growth37.00%
Earnings Growth—
Balance Sheet
Debt/Equity—
Current Ratio31.90
Quick Ratio24.56
Book Value/Sh2.957 EUR
Cash/Share0.5780 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateJun 16, 2023
Pay Date—
Ownership
Shares Out.12.61M
Float—
Insiders2.00%
Institutions9.82%
Analyst Consensus
Rating—
Target (Mean)4.400 EUR
Target Range4.300 EUR – 4.500 EUR
# Analysts2
Company
Market Cap19.30M EUR
Enterprise Value12.01M EUR
Revenue (TTM)5.17M EUR
Gross Profit2.95M EUR
Net Income (TTM)-2.05M EUR
Revenue/Share0.4100 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees20
Last Price1.490 EUR
CountryDE
SectorHealthcare
IndustryDiagnostics & Research
ISINDE0006577109